Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Irritable Bowel Syndrome (IBS): Treatment

Description: Irritable bowel syndrome, or IBS, is a disorder of the intestine that carries no structural lesions or pathophysiological explanations. Between 10 and 20% of the population in developed countries suffer from IBS, with almost 75% of those people reporting symptoms being female. While IBS is a widespread condition, only 20-30% of sufferers consult a doctor. This course introduces the treatment options available for this condition.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

TREATMENT
4. Objectives
5. Prognosis
6. Nutritional Support
7. Medication
8. Psychological Action
9. Progress Check

CONCLUSION
10. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe the prognosis for IBS
  • List the dietary changes necessary for an IBS patient
  • Name pharmacological aids used to treat IBS
  • Understand why psychological action may be beneficial for IBS patients

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy